<html>
<head>PUBMED IDs for C11orf95</head>
<body bgcolor='#C5F0F2'><h1>C11orf95</h1><a href='https://pubmed.ncbi.nlm.nih.gov/20607705/'>C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in chondroid lipoma.</a> October 26  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21274402/'>Contributions of cytogenetics and molecular cytogenetics to the diagnosis of adipocytic tumors.</a> June 1  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21274384/'>Silence of HIN-1 expression through methylation of its gene promoter in gastric cancer.</a> July 19  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21274376/'>A potential oncogenic role of the commonly observed E2F5 overexpression in hepatocellular carcinoma.</a> July 19  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23672313/'>Presence of C11orf95-MKL2 fusion is a consistent finding in chondroid lipomas: a study of eight cases.</a> December 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24553141/'>C11orf95-RELA fusions drive oncogenic NF-ÎºB signalling in ependymoma.</a> March 14  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25182241/'>Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.</a> May 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25388523/'>C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.</a> November 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25388470/'>[Investigation of the action mechanisms of poly-ADP-ribosylation in hexavalent chromium induced cell damage].</a> September 2  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26769252/'>Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.</a> August 10  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27121356/'>C11orf95-RELA fusion present in a primary intracranial extra-axial ependymoma: Report of a case with literature review.</a> April 29  2016<br></body></html>
